Merck

YTD

ALL

Trade Merck 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRK

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.

CEO

Robert M. Davis

CEORobert M. Davis

Employees

75,000

Employees75,000

Headquarters

Rahway, New Jersey

HeadquartersRahway, New Jersey

Founded

1891

Founded1891

Employees

75,000

Employees75,000

MRK Key Statistics

Market cap

239.27B

Market cap239.27B

Price-Earnings ratio

14.14

Price-Earnings ratio14.14

Dividend yield

3.28%

Dividend yield3.28%

Average volume

15.96M

Average volume15.96M

High today

$96.01

High today$96.01

Low today

$94.73

Low today$94.73

Open price

$95.02

Open price$95.02

Volume

18.36K

Volume18.36K

52 Week high

$134.63

52 Week high$134.63

52 Week low

$81.04

52 Week low$81.04

MRK News

Seeking Alpha 16h

Merck scores victory in Gardasil lawsuits as judge questions evidence

A federal judge in North Carolina on Tuesday granted an order for summary judgment in favor of Merck (NYSE:MRK) regarding lawsuits accusing the drugmaker of fai...

TipRanks 16h

Judge rules in Merck’s favor over Gardasil complaints, Bloomberg says

U.S. District Judge Kenneth Bell ruled in Merck’s (MRK) favor in a safety lawsuit over the company’s Gardasil vaccine, allowing the pharma giant to sidestep ove...

Simply Wall St 19h

Merck Unveils US$1 Billion Durham Facility For Advanced Vaccine Manufacturing Expansion

announced the opening of a new $1 billion vaccine manufacturing facility in Durham, North Carolina, a major development aligning with the company's broader $12...

Analyst ratings

64%

of 25 ratings

Buy

64%

Hold

36%

Sell

More MRK News

Benzinga 21h

Merck Injects $1 Billion To Expand Vaccine Production In US

On Tuesday, Merck & Co Inc MRK opened a new $1 billion, 225,000-square-foot facility for vaccine manufacturing at its Durham, North Carolina, site. This expans...

TipRanks 1d

Merck opens new vaccine manufacturing in Durham, North Carolina

Merck (MRK) announced the opening of a new, $1B, 225,000-square-foot facility dedicated to vaccine manufacturing at its Durham, North Carolina, site. This expan...

TipRanks 5d

iTeos Therapeutics: Poised for Success with Anti-TIGIT Therapies Amidst Competitive Landscape

Leerink Partners analyst Daina Graybosch maintained a Buy rating on iTeos Therapeutics (ITOS – Research Report) on March 5 and set a price target of $47.00. Da...

TipRanks 6d

Hold Rating for Merck & Company Amid Keytruda Patent Infringement Concerns

Merck & Company (MRK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Courtney Breen from Bernstein...

Seeking Alpha 7d

Moderna aims 2027 approval for Merck-partnered cancer shot

Moderna (NASDAQ:MRNA) is targeting market approval of a personalized vaccine the company is developing with Merck (NYSE:MRK) for skin cancer in 2027, one of its...

TipRanks 7d

Merck Battling to Protect Key Cancer Drug as Patent Row Heats Up

Shares in pharmaceuticals giant Merck (MRK) weakened today on fears that a patent battle could jeopardize its plans to sell a new version of its crucial cancer...